Nektar Therapeutics Soared

Tue, Jun 24, 2025 at 07:20 PM

Nektar Therapeutics (NKTR:NASDAQ) rocketted at $24.45, a gain of 156.3%. On Tue, Jun 24, 2025, NKTR:NASDAQ touched a New 2-Week High of $24.45. The stock appeared on our News Catalysts scanner on Tue, Jun 24, 2025 at 01:03 PM in the 'MISCELLANEOUS' category. From Tue, Jun 10, 2025, the stock recorded 33.33% Up Days and 60.00% Green Days

About Nektar Therapeutics (NKTR:NASDAQ)

Nektar Therapeutics Inc is a biopharmaceutical company engaged in the development of new molecules to treat diseases with unmet medical needs. The company's research and development activities involve small-molecule drugs, and peptides.

Top 10 Gainers:

Nektar Therapeutics (NKTR:NASDAQ), 156.29%
OneMedNet Corporation (ONMD:NASDAQ), 100.65%
Youxin Technology Ltd (YAAS:NASDAQ), 95.45%
Surf Air Mobility Inc. (SRFM:NYSE), 88.48%
Eyenovia, Inc. (EYEN:NASDAQ), 64.6%
Sound Group Inc. (SOGP:NASDAQ), 60.08%
InMed Pharmaceuticals Inc. (INM:NASDAQ), 57.96%
AIFU Inc. (AIFU:NASDAQ), 45.86%
Nano Labs Ltd (NA:NASDAQ), 36.36%
Rezolve AI PLC (RZLV:NASDAQ), 36.27%